This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nicolle Doering and Her Patent in Orexin Receptor Agonists.
Introduction
Nicolle Doering is an inventor based in San Diego, California, and is associated with Takeda Pharmaceutical Company Limited. Her patent work concerns a potential treatment approach for narcolepsy.
Latest Patents
Doering is named on 1 patent: “Macrocyclic Heterocycle Compounds and Use Thereof.” The invention describes heterocyclic compounds, or their salts, with orexin type 2 receptor agonist activity. The patent identifies these compounds as potentially useful for preventing or treating narcolepsy.
Career Highlights
The available information connects Doering’s patent activity with Takeda Pharmaceutical Company Limited and its pharmaceutical research. The patent reflects work on compounds that target the orexin type 2 receptor.
Collaborations
Doering’s listed coworkers include Mitsunori Kono and Yusuke Sasaki. Their names appear alongside hers in connection with the patent.
Conclusion
Nicolle Doering’s patent contribution focuses on orexin type 2 receptor agonists and their potential application in narcolepsy prevention or treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile